Dietary Geroprotective Peptides
Current understanding
Food-derived bioactive peptides from plant, animal, and marine sources are being framed as ‘natural geroprotectors’ claimed to modulate Nrf2, insulin/IGF-1 signaling, and mTOR while remodeling gut microbiota, with AI-driven discovery and synthetic-biology fermentation proposed to scale them into functional foods and nutraceuticals. Current backing is largely mechanism-plausible structure–activity mapping plus scattered animal-model readouts; direct healthspan or lifespan RCTs in humans for defined dietary peptides are essentially absent. Distinct from the injectable gray-market ‘peptides’ scene: overlaps thematically with food-medicine homology and natural GLP-1 agonist narratives.
Evidence log
- 2026-04-15 — Dietary geroprotective peptides: structural determinants, AI-driven discovery, and synthetic biology production for healthy ageing.: cross-connection with natural-glp1-agonists: Both are ‘food-derived molecule as geroprotector’ narratives targeting metabolic-aging pathways; dietary peptides broaden the frame beyond GLP-1 receptor agonism to Nrf2/IIS/mTOR. (novelty: 3)